Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring Plasma and Hemodynamic Markers in Patients Undergoing Liver Resection to Identify Pathophysiological Mechanisms and Predict Clinical Outcome

NCT01700231 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT01700231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01700231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring Plasma and Hemodynamic Markers in Patients Undergoing Liver Resection to Identify Pathophysiological Mechanisms and Predict Clinical Outcome
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
Not reported
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatorenal syndrome, liver regeneration